Analyst Ratings for Bio-Reference Laboratories (BRLI)
BRLI Rating Summary
BRLI Price Target Summary
- Highest: $30.00 (Benchmark)
- Lowest: $21.00 (Jefferies)
- Average: $25.50
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$25.50 (-17.1%)
Avg. $ Target:
$25.50 (-17.1%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/24/2012 | UBS | Downgrade | Neutral (Buy) |
N/A (N/A) |
27.09 | 30.75 | 13.51% | Details |
| 6/12/2012 | BofA/Merrill Lynch | Upgrade | Buy (Neutral) |
N/A (N/A) |
21.71 | 30.75 | 41.64% | Details |
| 4/6/2011 | Macquarie | New Coverage | Neutral (N/A) |
N/A (N/A) |
23.07 | 30.75 | 33.29% | Details |
| 1/31/2011 | Dougherty & Co | New Coverage | Buy (N/A) |
N/A (N/A) |
23.12 | 30.75 | 33% | Details |
